Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
暂无分享,去创建一个
Ronald J. Moore | Richard D. Smith | D. Camp | L. Paša-Tolić | W. Qian | Tao Liu | K. Rodland | R. Zhao | Tujin Shi | Fang Xie | J. Kagan | Mahmud Hossain | Si Wu | Xuefei Sun | Jong-Seo Kim | A. Schepmoes | Keqi Tang | T. Fillmore | N. Jones
[1] Scott R. Kronewitter,et al. Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests. , 2012, Journal of proteomics.
[2] Richard D. Smith,et al. Advancing the sensitivity of selected reaction monitoring‐based targeted quantitative proteomics , 2012, Proteomics.
[3] T. Pawson,et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor , 2011, Nature Biotechnology.
[4] S. Carr,et al. A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease , 2011, Nature Biotechnology.
[5] Pei Wang,et al. A targeted proteomics–based pipeline for verification of biomarkers in plasma , 2011, Nature Biotechnology.
[6] Ronald J. Moore,et al. Reversed‐phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells , 2011, Proteomics.
[7] K. Kinzler,et al. Mutant proteins as cancer-specific biomarkers , 2011, Proceedings of the National Academy of Sciences.
[8] Susan E Abbatiello,et al. Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry* , 2011, Molecular & Cellular Proteomics.
[9] R. Aebersold,et al. A quantitative targeted proteomics approach to validate predicted microRNA targets in C. elegans , 2010, Nature Methods.
[10] Ronald J. Moore,et al. Enhanced Sensitivity for Selected Reaction Monitoring Mass Spectrometry-based Targeted Proteomics Using a Dual Stage Electrodynamic Ion Funnel Interface* , 2010, Molecular & Cellular Proteomics.
[11] Brendan MacLean,et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments , 2010, Bioinform..
[12] Jason M. Held,et al. Targeted Quantitation of Site-Specific Cysteine Oxidation in Endogenous Proteins Using a Differential Alkylation and Multiple Reaction Monitoring Mass Spectrometry Approach , 2010, Molecular & Cellular Proteomics.
[13] Amanda G. Paulovich,et al. An Automated and Multiplexed Method for High Throughput Peptide Immunoaffinity Enrichment and Multiple Reaction Monitoring Mass Spectrometry-based Quantification of Protein Biomarkers* , 2009, Molecular & Cellular Proteomics.
[14] Lukas N. Mueller,et al. Full Dynamic Range Proteome Analysis of S. cerevisiae by Targeted Proteomics , 2009, Cell.
[15] R. Aebersold,et al. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans , 2009, Nature.
[16] Xu Shi,et al. Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution* , 2009, Molecular & Cellular Proteomics.
[17] Christoph H Borchers,et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.
[18] D R Mani,et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. , 2009, Clinical chemistry.
[19] A. Salvador,et al. Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests , 2009, Molecular & Cellular Proteomics.
[20] Christoph H Borchers,et al. Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma* , 2009, Molecular & Cellular Proteomics.
[21] Gennifer E. Merrihew,et al. Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. , 2009, Journal of proteome research.
[22] Andrew N Hoofnagle,et al. Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. , 2008, Clinical chemistry.
[23] R. Aebersold,et al. Selected reaction monitoring for quantitative proteomics: a tutorial , 2008, Molecular systems biology.
[24] David T. Kaleta,et al. Enhanced Detection of Low Abundance Human Plasma Proteins Using a Tandem IgY12-SuperMix Immunoaffinity Separation Strategy*S , 2008, Molecular & Cellular Proteomics.
[25] G. Nicol,et al. Use of an Immunoaffinity-Mass Spectrometry-based Approach for the Quantification of Protein Biomarkers from Serum Samples of Lung Cancer Patients* , 2008, Molecular & Cellular Proteomics.
[26] S. Carr,et al. Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.
[27] D. Lauffenburger,et al. Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks , 2007, Proceedings of the National Academy of Sciences.
[28] V. Srikantan,et al. Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome , 2006, Oncogene.
[29] Ronald J. Moore,et al. Evaluation of Multiprotein Immunoaffinity Subtraction for Plasma Proteomics and Candidate Biomarker Discovery Using Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.
[30] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[31] Leigh Anderson,et al. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.
[32] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[33] Darryl B. Hardie,et al. Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.
[34] S. Gygi,et al. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. G. Das,et al. Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10) , 2000, Clinical chemistry.
[36] A. Semjonow,et al. Discordance of assay methods creates pitfalls for the interpretation of prostate‐specific antigen values , 1996, The Prostate. Supplement.
[37] J. Oesterling,et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. , 1995, Urology.
[38] T. Stamey,et al. Clinical usefulness of free and complexed PSA. , 1995, Scandinavian journal of clinical and laboratory investigation. Supplementum.